South Africa · Delayed Price · Currency is ZAR · Price in ZAc Ascendis Health Statistics
Total Valuation
Ascendis Health has a market cap or net worth of ZAR 575.69 million. The enterprise value is 679.51 million.
| Market Cap | 575.69M |
| Enterprise Value | 679.51M |
Important Dates
The last earnings date was Friday, September 26, 2025.
| Earnings Date | Sep 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ascendis Health has 625.75 million shares outstanding.
| Current Share Class | 625.75M |
| Shares Outstanding | 625.75M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 16.46% |
| Owned by Institutions (%) | 0.09% |
| Float | 56.20M |
Valuation Ratios
The trailing PE ratio is 51.07.
| PE Ratio | 51.07 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.91 |
| P/TBV Ratio | 0.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 60.26 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -54.89 |
Financial Position
The company has a current ratio of 0.23, with a Debt / Equity ratio of 0.17.
| Current Ratio | 0.23 |
| Quick Ratio | 0.04 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | -8.62 |
| Interest Coverage | -4.55 |
Financial Efficiency
Return on equity (ROE) is 1.81% and return on invested capital (ROIC) is -3.45%.
| Return on Equity (ROE) | 1.81% |
| Return on Assets (ROA) | -2.64% |
| Return on Invested Capital (ROIC) | -3.45% |
| Return on Capital Employed (ROCE) | -6.14% |
| Revenue Per Employee | n/a |
| Profits Per Employee | 805,500 |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.84M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +31.43% in the last 52 weeks. The beta is 0.43, so Ascendis Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | +31.43% |
| 50-Day Moving Average | 84.58 |
| 200-Day Moving Average | 83.85 |
| Relative Strength Index (RSI) | 63.41 |
| Average Volume (20 Days) | 115,626 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -38.81M |
| Pretax Income | 8.44M |
| Net Income | 11.28M |
| EBITDA | -38.78M |
| EBIT | -38.81M |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 2.95 million in cash and 106.78 million in debt, giving a net cash position of -103.82 million or -0.17 per share.
| Cash & Cash Equivalents | 2.95M |
| Total Debt | 106.78M |
| Net Cash | -103.82M |
| Net Cash Per Share | -0.17 |
| Equity (Book Value) | 629.73M |
| Book Value Per Share | 1.01 |
| Working Capital | -112.25M |
Cash Flow
In the last 12 months, operating cash flow was -12.25 million and capital expenditures -135,000, giving a free cash flow of -12.38 million.
| Operating Cash Flow | -12.25M |
| Capital Expenditures | -135,000 |
| Free Cash Flow | -12.38M |
| FCF Per Share | -0.02 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Ascendis Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 1.96% |
| FCF Yield | -2.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |